Literature DB >> 21461155

In vitro effects of Warburgia ugandensis, Psiadia punctulata and Chasmanthera dependens on Leishmania major promastigotes.

Edward K Githinji1, Lucy W Irungu, Willy K Tonui, Geoffrey M Rukunga, Charles Mutai, Charles N Muthaura, Reuben Lugalia, Geoffrey Gikandi, Caroline W Wainaina, Johnston M Ingonga, Antony Wanjoya.   

Abstract

Plant extracts from Warburgia ugandensis Sprague (Family: Canellaceae), Psiadia punctulata Vatke (Family: Compositae) and Chasmanthera dependens Hoschst (Family: Menispermaceae) were tested for activity on Leishmania major promastigotes (Strain IDU/KE/83 = NLB-144) and infected macrophages in vitro. Plants were collected from Baringo district, dried, extracted, weighed and tested for antileishmanial activity. Serial dilutions of the crude extracts were assayed for their activity against Leishmania major in cell free cultures and in infected macrophages in vitro. Inhibitory concentrations and levels of cytotoxicity were determined. Warburgia ugandensis, Psiadia punctulata and Chasmanthera dependens had an IC(50) of 1.114 mg/ml, 2.216 mg/ml and 4.648 mg/ml, respectively. The cytotoxicity of the drugs on BALB/c peritoneal macrophage cells was insignificant as compared to the highly toxic drug of choice Pentostam(®). The supernatants from control and Leishmania infected macrophages were analyzed for their nitrite contents by Griess reaction and nitrite absorbance measured at 540 nm. Warburgia ugandensis (stem bark water extract), Chasmanthera dependens (stem bark water extract) and Psiadia punctulata (stem bark methanol extract) produced 112.3%, 94% and 88.5% more nitric oxide than the untreated infected macrophages respectively. Plant crude extracts had significant (p<0.05) anti-leishmanial and immunomodulative effects but insignificant cytotoxic effects at 1mg/ml concentration. All experiments were performed in triplicate. Statistical analysis of the differences between mean values obtained from the experimental group compared to the controls was done by students't test. ANOVA was used to determine the differences between the various treatment groups. The analysis program Probit was used to determine IC(50)s.

Entities:  

Keywords:  Chasmanthera dependens; Psiadia punctulata; Warburgia ugandensis; anti-leishmanial activity; cytotoxicity and immunomodulative effects

Mesh:

Substances:

Year:  2010        PMID: 21461155      PMCID: PMC3025625          DOI: 10.4314/ajtcam.v7i3.54791

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  22 in total

1.  Semiautomated measurement of nitrate in biological fluids.

Authors:  J A Navarro-Gonzálvez; C García-Benayas; J Arenas
Journal:  Clin Chem       Date:  1998-03       Impact factor: 8.327

2.  Antileishmanial activity of an indole alkaloid from Peschiera australis.

Authors:  J C Delorenzi; M Attias; C R Gattass; M Andrade; C Rezende; A da Cunha Pinto ; A T Henriques; D C Bou-Habib; E M Saraiva
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

3.  Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2.

Authors:  W W Zhang; G Matlashewski
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

Review 4.  Visceral leishmaniasis control: a public health perspective.

Authors:  M Boelaert; B Criel; J Leeuwenburg; W Van Damme; D Le Ray; P Van der Stuyft
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Sep-Oct       Impact factor: 2.184

Review 5.  Chemotherapy of leishmaniasis.

Authors:  Simon L Croft; Vanessa Yardley
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

6.  Cutaneous leishmaniasis in Kenya: transmission of Leishmania major to man by the bite of a naturally infected Phlebotomus duboscqi.

Authors:  R Beach; G Kiilu; L Hendricks; C Oster; J Leeuwenburg
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

7.  Bioassay-guided studies on the cytotoxic and in vitro trypanocidal activities of a sesquiterpene (Muzigadial) derived from a Ugandan medicinal plant (Warburgia ugandensis).

Authors:  D Olila; J Opuda-Asibo
Journal:  Afr Health Sci       Date:  2001-08       Impact factor: 0.927

8.  Estimation of population at risk of infection and number of cases of Leishmaniasis.

Authors:  R W Ashford; P Desjeux; P Deraadt
Journal:  Parasitol Today       Date:  1992-03

9.  Polygodial, an antifungal potentiator.

Authors:  I Kubo; M Taniguchi
Journal:  J Nat Prod       Date:  1988 Jan-Feb       Impact factor: 4.050

10.  Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes.

Authors:  Philippe Holzmuller; Denis Sereno; Mireille Cavaleyra; Isabelle Mangot; Sylvie Daulouede; Philippe Vincendeau; Jean-Loup Lemesre
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  4 in total

1.  Warburgia ugandensis Leaf and Bark Extracts: An Alternative to Copper as Fungicide against Downy Mildew in Organic Viticulture?

Authors:  Christian Kraus; Rada Abou-Ammar; Andreas Schubert; Michael Fischer
Journal:  Plants (Basel)       Date:  2021-12-14

2.  Pharmacological Assessment of the Antiprotozoal Activity, Cytotoxicity and Genotoxicity of Medicinal Plants Used in the Treatment of Malaria in the Greater Mpigi Region in Uganda.

Authors:  Fabien Schultz; Ogechi Favour Osuji; Anh Nguyen; Godwin Anywar; John R Scheel; Guy Caljon; Luc Pieters; Leif-Alexander Garbe
Journal:  Front Pharmacol       Date:  2021-06-30       Impact factor: 5.810

Review 3.  Exploring the role of medicinal plant-based immunomodulators for effective therapy of leishmaniasis.

Authors:  Garima Chouhan; Mohammad Islamuddin; Dinkar Sahal; Farhat Afrin
Journal:  Front Immunol       Date:  2014-05-05       Impact factor: 7.561

4.  The Anti-leishmanial Efficacy of Artemisia dracunculus Ethanolic Extract in Vitro and Its Effects on IFN-γ and IL-4 Response.

Authors:  Reza Rezaei; Khosrow Hazrati Tappeh; Shahram Seyyedi; Peyman Mikaili
Journal:  Iran J Parasitol       Date:  2017 Jul-Sep       Impact factor: 1.012

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.